This company has been marked as potentially delisted and may not be actively trading. Elevation Oncology (ELEV) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesOwnershipShort InterestTrendsBuy This Stock Get the Latest News and Ratings for ELEV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Elevation Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELEV Analyst Ratings Over TimeTypeCurrent Forecast9/25/24 to 9/25/251 Month Ago8/26/24 to 8/26/253 Months Ago6/27/24 to 6/27/251 Year Ago9/26/23 to 9/25/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)5 Buy rating(s)Hold11 Hold rating(s)11 Hold rating(s)11 Hold rating(s)0 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$2.62$2.62$3.39$7.80Forecasted Upside616.89% Upside616.89% Upside834.51% Upside1,249.48% UpsideConsensus RatingHoldHoldHoldBuy ELEV Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ELEV Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Elevation Oncology Stock vs. The CompetitionTypeElevation OncologyMedical CompaniesS&P 500Consensus Rating Score 2.00 2.78 2.53Consensus RatingHoldModerate BuyModerate BuyPredicted Upside616.89% Upside1,730.51% Upside11.58% UpsideNews Sentiment RatingNeutral NewsSee Recent ELEV NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails6/10/2025JMP Securities3 of 5 starsSilvan Tuerkcan1 of 5 starsReiterated RatingMarket Perform6/10/2025HC Wainwright1 of 5 starsSwayampakula Ramakanth1 of 5 starsDowngradeStrong-Buy ➝ Neutral6/9/2025TD Cowen4 of 5 starsM. Frahm Not RatedDowngradeStrong-Buy ➝ Hold6/9/2025William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingA. HsiehSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/24/2025StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSudan LoganathanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOverweight ➝ Equal Weight$5.00 ➝ $1.00+233.21%3/21/2025CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeMarket Perform3/21/2025Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAndrew BerensSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$9.00 ➝ $1.00+259.70%3/21/2025Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingS. TuerkcanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform3/21/2025Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBiren AminSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$10.00 ➝ $0.70+151.79%3/20/2025WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingR. DriscollSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 3/20/2025Leerink PartnrsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingA. BerensSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ HoldAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:21 AM ET. ELEV Forecast - Frequently Asked Questions What is Elevation Oncology's forecast for 2025? According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Elevation Oncology is $2.62, with a high forecast of $7.00 and a low forecast of $0.70. Should I buy or sell Elevation Oncology stock right now? 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elevation Oncology in the last year. There are currently 11 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ELEV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ELEV, but not buy additional shares or sell existing shares. Does Elevation Oncology's stock price have much upside? According to analysts, Elevation Oncology's stock has a predicted upside of 616.89% based on their 12-month stock forecasts. Do Wall Street analysts like Elevation Oncology more than its competitors? Analysts like Elevation Oncology less than other "medical" companies. The consensus rating for Elevation Oncology is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ELEV compares to other companies. Stock Forecasts and Research Tools Related Companies OVID Stock Forecast QNCX Stock Forecast KLRS Stock Forecast ATRA Stock Forecast IMUX Stock Forecast ENTX Stock Forecast ADVM Stock Forecast MGX Stock Forecast ABOS Stock Forecast STRO Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:ELEV) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
